Updated: February 5, 2026
Motpoly XR Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Overview
Is there a Motpoly XR shortage in 2026? Get the latest update on availability, why some patients struggle to find it, and what to do if you can't fill your prescription.
Is Motpoly XR in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Motpoly XR near you.
Patients prescribed Motpoly XR are asking an important question: is this medication in shortage? Here's the most current information available as of 2026, along with what to do if you're struggling to fill your prescription.
Is There an Official Motpoly XR Shortage in 2026?
As of 2026, the FDA has not declared an active shortage of Motpoly XR. The FDA's drug shortage database tracks supply disruptions reported by manufacturers, and Aucta Pharmaceuticals has not reported a supply issue with Motpoly XR. This means the drug is being manufactured and distributed — the supply chain is not broken.
However, "no shortage" is different from "easy to find at every pharmacy." Motpoly XR's access challenges are structural rather than a supply crisis — they stem from the drug's novelty, brand-only status, and insurance hurdles rather than a manufacturing breakdown.
Check live stock now.
Why Motpoly XR Can Still Be Difficult to Access in 2026
Several factors create real-world access challenges for Motpoly XR patients in 2026:
Limited pharmacy stocking. Because Motpoly XR was approved in 2023 and is still gaining prescriber adoption, many pharmacies don't routinely stock it. Pharmacies order based on their patient base's demand — if demand at your location is low, stock may be zero.
Brand-only medication. No generic version of Motpoly XR exists. Brand-name-only drugs have a smaller pharmacy footprint than generics.
Insurance access barriers. Prior authorization requirements and step therapy protocols can delay access even when the drug is physically available.
Schedule V controlled substance. Some pharmacies are more selective about which controlled substances they stock at what quantities.
Is Motpoly XR New? Understanding Its Market History
Motpoly XR is a relatively new drug — FDA-approved May 4, 2023. That makes it just over three years old as of 2026. Its active ingredient, lacosamide, has been available since 2008 as Vimpat (and as generic lacosamide IR since Vimpat's patent exclusivity ended). The XR formulation was developed by Aucta Pharmaceuticals specifically to offer once-daily dosing as a convenience improvement over twice-daily Vimpat.
In June 2024, the FDA expanded Motpoly XR's approved indication to include adjunctive treatment of primary generalized tonic-clonic (PGTC) seizures — bringing it in line with Vimpat's broader approval. This means more patients may now be prescribed Motpoly XR, gradually increasing pharmacy demand and stocking.
What Patients Can Do Right Now
If you're struggling to access Motpoly XR, here's a practical action plan:
Don't wait until you're out. Start searching for your next fill 10–14 days in advance.
Call pharmacies directly. Ask specifically for "Motpoly XR lacosamide extended-release capsules" in your strength (100 mg, 150 mg, or 200 mg).
Ask your pharmacy to special order it. If your regular pharmacy doesn't have it, they can order it from their wholesaler, typically within 1–2 business days.
Check your insurance PA status. If prior authorization is the barrier, call your prescriber's office and ask them to expedite the PA submission.
Use the Aucta copay card. Eligible commercially insured patients can pay as little as $10/month. Ask your pharmacist or doctor about enrollment.
Emergency: What to Do If You're About to Run Out
If you are within 3 days of running out and cannot locate Motpoly XR:
Call your neurologist or prescriber immediately — explain the urgency
Ask for a bridge prescription for generic lacosamide IR (same active ingredient, twice-daily dosing)
Ask if your doctor has Motpoly XR samples on hand
Do NOT stop taking Motpoly XR abruptly — this can cause status epilepticus
Using medfinder to Locate Motpoly XR
Rather than calling pharmacies yourself, medfinder calls local pharmacies on your behalf to check which ones have Motpoly XR in your specific strength and quantity. You tell medfinder your medication and location; medfinder handles the calling and texts you which pharmacies can fill your prescription.
Also see: Alternatives to Motpoly XR if You Can't Fill Your Prescription for more options.
Frequently Asked Questions
As of 2026, Motpoly XR is not listed on the FDA's drug shortage database. There is no declared national shortage. Access difficulties most patients experience are due to limited pharmacy stocking, insurance barriers, and the drug's brand-only status — not a supply chain disruption.
Motpoly XR (lacosamide extended-release capsules) was first FDA-approved on May 4, 2023 for partial-onset seizures. The FDA expanded its approval on June 7, 2024 to include adjunctive treatment of primary generalized tonic-clonic seizures in adults and children weighing at least 50 kg.
Likely yes. As more neurologists prescribe Motpoly XR and patient demand at pharmacies grows, more locations will routinely stock it. The June 2024 expanded indication for PGTC seizures has broadened the patient population, which should increase stocking at more pharmacies over time.
Start looking 10–14 days before you run out. This gives you enough time to locate a pharmacy, place a special order if needed, and resolve any insurance issues without risking a gap in your treatment. Never wait until you have fewer than 3 days' supply before addressing access issues.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Motpoly XR also looked for:
More about Motpoly XR
38,224 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





